InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.44) earnings per share (EPS) for the quarter, Zacks reports. InMed Pharmaceuticals had a negative net margin of 171.13% and a negative return on equity of 92.47%. InMed Pharmaceuticals Stock Down 6.2% NASDAQ INM traded down $0.11 on [...]
InMed Pharmaceuticals (NASDAQ:INM) Posts Earnings Results
